Multimodality Imaging of Hepatocellular Carcinoma: From Diagnosis to Treatment Response Assessment in Everyday Clinical Practice

被引：5

作者：

Pizzi, Andrea Delli ^{[1
,2
]}

Mastrodicasa, Domenico ^{[3
]}

Cianci, Roberta ^{[2
]}

Serafini, Francesco Lorenzo ^{[2
]}

Mincuzzi, Erica ^{[2
]}

Di Fabio, Francesca ^{[2
]}

Giammarino, Alberto ^{[2
]}

Mannetta, Gianluca ^{[2
]}

Basilico, Raffaella ^{[2
]}

Caulo, Massimo ^{[1
,2
]}

机构：

[1] Univ G dAnnunzio, ITAB Inst Adv Biomed Technol, Chieti, Italy

[2] Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy

[3] Stanford Univ, Dept Radiol, Sch Med, Stanford, CA 94305 USA

来源：

CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES | 2021年 / 72卷 / 04期

关键词：

hepatocarcinoma; LI-RADS; MRI; CT; US; CEUS; treatment response; management; DISODIUM-ENHANCED MRI; RADS MAJOR FEATURES; US LI-RADS; GADOXETIC ACID; COMPUTED-TOMOGRAPHY; HEPATOBILIARY PHASE; TRANSARTERIAL CHEMOEMBOLIZATION; DATA SYSTEM; LIVER; CT;

D O I：

10.1177/0846537120923982

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

The Liver Imaging Reporting and Data System (LI-RADS) is a recently developed classification aiming to improve the standardization of liver imaging assessment in patients at risk of developing hepatocellular carcinoma (HCC). The LI-RADS v2017 implemented new algorithms for ultrasound (US) screening and surveillance, contrast-enhanced US diagnosis and computed tomography/magnetic resonance imaging treatment response assessment. A minor update of LI-RADS was released in 2018 to comply with the American Association for the Study of the Liver Diseases guidance recommendations. The scope of this review is to provide a practical overview of LI-RADS v2018 focused both on the multimodality HCC diagnosis and treatment response assessment.

引用

页码：714 / 727

页数：14

共 55 条

[1] The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015 [J].

Akinyemiju, Tomi ;

Abera, Semaw ;

Ahmed, Muktar ;

Alam, Noore ;

Alemayohu, Mulubirhan Assefa ;

Allen, Christine ;

Al-Raddadi, Rajaa ;

Alvis-Guzman, Nelson ;

Amoako, Yaw ;

Artaman, Al ;

Ayele, Tadesse Awoke ;

Barac, Aleksandra ;

Bensenor, Isabela ;

Berhane, Adugnaw ;

Bhutta, Zulfiqar ;

Castillo-Rivas, Jacqueline ;

Chitheer, Abdulaal ;

Choi, Jee-Young ;

Cowie, Benjamin ;

Dandona, Lalit ;

Dandona, Rakhi ;

Dey, Subhojit ;

Dicker, Daniel ;

Phuc, Huyen ;

Ekwueme, Donatus U. ;

Zaki, Maysaa El Sayed ;

Fischer, Florian ;

Furst, Thomas ;

Hancock, Jamie ;

Hay, Simon I. ;

Hotez, Peter ;

Jee, Sun Ha ;

Kasaeian, Amir ;

Khader, Yousef ;

Khang, Young-Ho ;

Kumar, G. Anil ;

Kutz, Michael ;

Larson, Heidi ;

Lopez, Alan ;

Lunevicius, Raimundas ;

Malekzadeh, Reza ;

McAlinden, Colm ;

Meier, Toni ;

Mendoza, Walter ;

Mokdad, Ali ;

Moradi-Lakeh, Maziar ;

Nagel, Gabriele ;

Nguyen, Quyen ;

Nguyen, Grant ;

Ogbo, Felix .

JAMA ONCOLOGY, 2017, 3 (12) :1683-1691

[2] Screening for hepatocellular carcinoma in cirrhosis [J].

Bolondi, L .

JOURNAL OF HEPATOLOGY, 2003, 39 (06) :1076-1084

[3] Management of Hepatocellular Carcinoma: An Update [J].

Bruix, Jordi ;

Sherman, Morris .

HEPATOLOGY, 2011, 53 (03) :1020-1022

[4] MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: comparison of gadoxetic acid and gadobenate dimeglumine [J].

Burgio, Marco Dioguardi ;

Picone, Dario ;

Cabibbo, Giuseppe ;

Midiri, Massimo ;

Lagalla, Roberto ;

Brancatelli, Giuseppe .

ABDOMINAL RADIOLOGY, 2016, 41 (08) :1546-1554

[5] LI-RADS® ancillary features on CT and MRI [J].

Chernyak, Victoria ;

Tang, An ;

Flusberg, Milana ;

Papadatos, Demetri ;

Bijan, Bijan ;

Kono, Yuko ;

Santillan, Cynthia .

ABDOMINAL RADIOLOGY, 2018, 43 (01) :82-100

[6] Diagnostic criteria for hepatocellular carcinoma ≤3 cm with hepatocyte-specific contrast-enhanced magnetic resonance imaging [J].

Choi, Sang Hyun ;

Byun, Jae Ho ;

Lim, Young-Suk ;

Yu, Eunsil ;

Lee, So Jung ;

Kim, So Yeon ;

Won, Hyung Jin ;

Shin, Yong Moon ;

Kim, Pyo Nyun .

JOURNAL OF HEPATOLOGY, 2016, 64 (05) :1099-1107

[7] Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI [J].

Chong, Y. S. ;

Kim, Y. K. ;

Lee, M. W. ;

Kim, S. H. ;

Lee, W. J. ;

Rhim, H. C. ;

Lee, S. J. .

CLINICAL RADIOLOGY, 2012, 67 (08) :766-773

[8] Enhancement Patterns of Hepatocellular Carcinoma After Transarterial Chemoembolization Using Drug-Eluting Beads on Arterial Phase CT Images: A Pilot Retrospective Study [J].

Chung, Woo-Suk ;

Lee, Kwang-Hun ;

Park, Mi-Suk ;

Lee, Yeo Jin ;

Kwon, Joonho ;

Baek, Song-Ee ;

Kim, Myeong-Jin .

AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 199 (02) :349-359

[9] Gadoxetate Disodium-Enhanced MRI of the Liver: Part 2, Protocol Optimization and Lesion Appearance in the Cirrhotic Liver [J].

Cruite, Irene ;

Schroeder, Michael ;

Merkle, Elmar M. ;

Sirlin, Claude B. .

AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 195 (01) :29-41

[10] Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US [J].

Darnell, Anna ;

Forner, Alejandro ;

Rimola, Jordi ;

Reig, Maria ;

Garcia-Criado, Angeles ;

Ayuso, Carmen ;

Bruix, Jordi .

RADIOLOGY, 2015, 275 (03) :698-707

← 1 2 3 4 5 6 →